# A Study to Investigate Use Patterns and Safety in Simulated Actual Over-the-counter (OTC) Use of Rabeprazole Sodium for the Treatment of Heartburn Symptoms

> **NCT01286194** · — · COMPLETED · sponsor: **Eisai Inc.** · enrollment: 1500 (estimated)

## Conditions studied

- Frequent Heartburn

## Interventions

- **DRUG:** Rabeprazole sodium

## Key facts

- **NCT ID:** NCT01286194
- **Lead sponsor:** Eisai Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2006-04
- **Primary completion:** —
- **Final completion:** 2007-01
- **Target enrollment:** 1500 (ESTIMATED)
- **Last updated:** 2011-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01286194

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01286194, "A Study to Investigate Use Patterns and Safety in Simulated Actual Over-the-counter (OTC) Use of Rabeprazole Sodium for the Treatment of Heartburn Symptoms". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01286194. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*